Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer

OBJECTIVES: To determine the outcome of patients with luminal A, luminal B, human epidermal growth factor receptor-2 (HER-2) positive, and triple negative molecular subtypes of inflammatory breast cancer (IBC) using a retrospective analysis. METHODS: This study was conducted between February 2004 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jingyu, Yan, Yi, Guo, Lei, Ou, Huiying, Hai, Jian, Zhang, Chaojie, Wu, Zhaoyun, Tang, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362150/
https://www.ncbi.nlm.nih.gov/pubmed/25399208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362150/
https://www.ncbi.nlm.nih.gov/pubmed/25399208

Ejemplares similares